Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy - Drugs.com MedNews
Links shared publicly online about this topic.
- 588total visits
Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy - Drugs.com MedNews
Company Highlights Clinical Progress, Advances toward Commercial Preparedness at J.P. Morgan Healthcare Conference SAN FRANCISCO, Enobia Pharma Inc., today anno
View full resource at drugs.com
Tags: Bone, Drug, Healthcare, Pharma, Children's Health
Most Recently Shared on January 11, 2011 at 7:13 pm By:
Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Repl... http://bit.ly/ggrK1d #drug
Enobia Announces Successful Completion Of Phase II Juvenile Study Of ENB-0040, A Bone Targeted Enzyme Replacement Therapy
medicalnewstoday.com — “Enobia Pharma Inc., announced that it has successfully completed a Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in juveniles with hypophosphatasia (HPP” View full resource at medicalnewstoday.com
Most Recently Shared on January 11, 2011 at 3:05 pm By:
MNT Bones/Orthopedic Health News
Enobia Announces Successful Completion Of Phase II Juvenile Study Of ENB-0040, A Bone Targeted Enzyme Replacement Therapy http://mnt.to/3PR3
Advertisement
